THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES

Detalhes bibliográficos
Autor(a) principal: Kasprowicz, Julia Nahir
Data de Publicação: 2022
Outros Autores: Savi, Daiani Cristina
Tipo de documento: Artigo
Idioma: por
Título da fonte: Vittalle (Online)
Texto Completo: https://periodicos.furg.br/vittalle/article/view/13950
Resumo: The direct link between the gut-brain axis is increasingly debated as an important factor in the development of mental illness, particularly in major depressive disorder. There is a bidirectional communication axis between brain and gut, where abnormalities in the gut microbiota affect the brain and behavior. In this sense, disturbances in the intestinal microbiota, which favor dysbiosis, are considered a risk factor for depressive disorder, and the regulation of this can be a method of therapy and prevention of depression. The present study analyzed the impact of probiotic treatment for major depressive disorder through an integrative literature review of clinical trials published in the last 5 years. In total, 8 articles were selected, in which the studied bacteria belong to the Bifidobacterium, Lactobacillus and Lactococcus genera. The articles indicate that intervention with probiotics acts in major depressive disorder through three mechanisms of action. The first refers to the production of short-chain fatty acids, reducing intestinal pH and slowing the growth of pathogenic bacteria. Promoting the synthesis of IgA which protects the intestinal barrier, preventing the passage of LPS into the circulation, decreasing systemic inflammation. Finally, by increasing the plasma levels of tryptophan and decreasing the concentration of kynurenine, consequently improving the production of serotonin. Thus, the care about the intestinal microbiota and the use of probiotics can help in the treatment of depressive disorders and also in the prevention, acting as a new therapeutic option.
id FURG-6_b3cdec40c6832002f9ddda23f64eea89
oai_identifier_str oai:periodicos.furg.br:article/13950
network_acronym_str FURG-6
network_name_str Vittalle (Online)
repository_id_str
spelling THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIESO papel da microbiota intestinal nos transtornos depressivos: uma revisão sobre o tema e estudos clínicosProbióticostranstorno depressivo maioreixo microbiota-intestino-cérebrodisbioseThe direct link between the gut-brain axis is increasingly debated as an important factor in the development of mental illness, particularly in major depressive disorder. There is a bidirectional communication axis between brain and gut, where abnormalities in the gut microbiota affect the brain and behavior. In this sense, disturbances in the intestinal microbiota, which favor dysbiosis, are considered a risk factor for depressive disorder, and the regulation of this can be a method of therapy and prevention of depression. The present study analyzed the impact of probiotic treatment for major depressive disorder through an integrative literature review of clinical trials published in the last 5 years. In total, 8 articles were selected, in which the studied bacteria belong to the Bifidobacterium, Lactobacillus and Lactococcus genera. The articles indicate that intervention with probiotics acts in major depressive disorder through three mechanisms of action. The first refers to the production of short-chain fatty acids, reducing intestinal pH and slowing the growth of pathogenic bacteria. Promoting the synthesis of IgA which protects the intestinal barrier, preventing the passage of LPS into the circulation, decreasing systemic inflammation. Finally, by increasing the plasma levels of tryptophan and decreasing the concentration of kynurenine, consequently improving the production of serotonin. Thus, the care about the intestinal microbiota and the use of probiotics can help in the treatment of depressive disorders and also in the prevention, acting as a new therapeutic option.A ligação direta do eixo intestino-cérebro é cada vez mais debatida como um fator importante no desenvolvimento das doenças mentais, principalmente no transtorno depressivo maior. Há um eixo de comunicação bidirecional entre cérebro e intestino, onde anormalidades na microbiota intestinal afetam o cérebro e o comportamento. Neste sentido, as perturbações na microbiota intestinal, que favorecem a disbiose, são consideradas fator de risco chave para o transtorno depressivo, e a regulação desta é um método de terapia e prevenção da depressão. O presente estudo analisou o impacto do tratamento com probióticos no desenvolvimento do transtorno depressivo maior, por meio de uma revisão bibliográfica integrativa de estudos clínicos publicados nos últimos 5 anos.  Ao total, foram selecionados 8 artigos, nos quais as bactérias estudadas pertencem aos gêneros Bifidobacterium, Lactobacillus e Lactococcus. Os artigos apontam que a intervenção com probióticos atua no transtorno depressivo maior por três mecanismos de ação. Referindo-se a produção de ácidos graxos de cadeia curta, reduzindo o pH intestinal e retardando o crescimento de bactérias patogênicas. Promovendo a síntese de IgA a qual protege a barreira intestinal, impedindo a passagem de LPS para a circulação, diminuindo a inflamação sistêmica. Por fim, através do aumento dos níveis plasmáticos de triptofano e a diminuição da concentração de quinurenina, consequentemente melhorando a produção de serotonina. Assim, o cuidado com a microbiota intestinal e o uso de probióticos pode auxiliar no tratamento de transtornos depressivos e também na prevenção, atuando como uma nova opção terapêutica.Universidade Federal do Rio Grande2022-12-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.furg.br/vittalle/article/view/1395010.14295/vittalle.v34i3.13950VITTALLE - Revista de Ciências da Saúde; v. 34 n. 3 (2022); 8-192177-78531413-3563reponame:Vittalle (Online)instname:Universidade Federal do Rio Grande (FURG)instacron:FURGporhttps://periodicos.furg.br/vittalle/article/view/13950/9978Copyright (c) 2022 VITTALLE - Revista de Ciências da Saúdeinfo:eu-repo/semantics/openAccessKasprowicz, Julia Nahir Savi, Daiani Cristina2022-12-22T20:52:16Zoai:periodicos.furg.br:article/13950Revistahttps://periodicos.furg.br/vittallePUBhttps://periodicos.furg.br/vittalle/oaivittalle@furg.br2177-78531413-3563opendoar:2022-12-22T20:52:16Vittalle (Online) - Universidade Federal do Rio Grande (FURG)false
dc.title.none.fl_str_mv THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
O papel da microbiota intestinal nos transtornos depressivos: uma revisão sobre o tema e estudos clínicos
title THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
spellingShingle THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
Kasprowicz, Julia Nahir
Probióticos
transtorno depressivo maior
eixo microbiota-intestino-cérebro
disbiose
title_short THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
title_full THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
title_fullStr THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
title_full_unstemmed THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
title_sort THE ROLE OF INTESTINAL MICROBIOTA IN DEPRESSIVE DISORDERS: A REVIEW OF CLINICAL STUDIES
author Kasprowicz, Julia Nahir
author_facet Kasprowicz, Julia Nahir
Savi, Daiani Cristina
author_role author
author2 Savi, Daiani Cristina
author2_role author
dc.contributor.author.fl_str_mv Kasprowicz, Julia Nahir
Savi, Daiani Cristina
dc.subject.por.fl_str_mv Probióticos
transtorno depressivo maior
eixo microbiota-intestino-cérebro
disbiose
topic Probióticos
transtorno depressivo maior
eixo microbiota-intestino-cérebro
disbiose
description The direct link between the gut-brain axis is increasingly debated as an important factor in the development of mental illness, particularly in major depressive disorder. There is a bidirectional communication axis between brain and gut, where abnormalities in the gut microbiota affect the brain and behavior. In this sense, disturbances in the intestinal microbiota, which favor dysbiosis, are considered a risk factor for depressive disorder, and the regulation of this can be a method of therapy and prevention of depression. The present study analyzed the impact of probiotic treatment for major depressive disorder through an integrative literature review of clinical trials published in the last 5 years. In total, 8 articles were selected, in which the studied bacteria belong to the Bifidobacterium, Lactobacillus and Lactococcus genera. The articles indicate that intervention with probiotics acts in major depressive disorder through three mechanisms of action. The first refers to the production of short-chain fatty acids, reducing intestinal pH and slowing the growth of pathogenic bacteria. Promoting the synthesis of IgA which protects the intestinal barrier, preventing the passage of LPS into the circulation, decreasing systemic inflammation. Finally, by increasing the plasma levels of tryptophan and decreasing the concentration of kynurenine, consequently improving the production of serotonin. Thus, the care about the intestinal microbiota and the use of probiotics can help in the treatment of depressive disorders and also in the prevention, acting as a new therapeutic option.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.furg.br/vittalle/article/view/13950
10.14295/vittalle.v34i3.13950
url https://periodicos.furg.br/vittalle/article/view/13950
identifier_str_mv 10.14295/vittalle.v34i3.13950
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.furg.br/vittalle/article/view/13950/9978
dc.rights.driver.fl_str_mv Copyright (c) 2022 VITTALLE - Revista de Ciências da Saúde
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 VITTALLE - Revista de Ciências da Saúde
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal do Rio Grande
publisher.none.fl_str_mv Universidade Federal do Rio Grande
dc.source.none.fl_str_mv VITTALLE - Revista de Ciências da Saúde; v. 34 n. 3 (2022); 8-19
2177-7853
1413-3563
reponame:Vittalle (Online)
instname:Universidade Federal do Rio Grande (FURG)
instacron:FURG
instname_str Universidade Federal do Rio Grande (FURG)
instacron_str FURG
institution FURG
reponame_str Vittalle (Online)
collection Vittalle (Online)
repository.name.fl_str_mv Vittalle (Online) - Universidade Federal do Rio Grande (FURG)
repository.mail.fl_str_mv vittalle@furg.br
_version_ 1797041721534578688